An update on laboratory measurements of Dabigatran: smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma
J Amiral, C Dunois, C Amiral, J Seghatchian - Transfusion and Apheresis …, 2016 - Elsevier
Abstract Use of Direct Oral Anticoagulants (DOACs) is continuously increasing for clinical
application. The first product released was Dabigatran, which was proposed for many …
application. The first product released was Dabigatran, which was proposed for many …
An update on laboratory measurements of Dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma
J Amiral, C Dunois, C Amiral, J Seghatchian - Transfusion and Apheresis …, 2016 - infona.pl
Use of Direct Oral Anticoagulants (DOACs) is continuously increasing for clinical application.
The first product released was Dabigatran, which was proposed for many preventive and …
The first product released was Dabigatran, which was proposed for many preventive and …
An update on laboratory measurements of Dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma
J Amiral, C Dunois, C Amiral… - … : official journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
Use of Direct Oral Anticoagulants (DOACs) is continuously increasing for clinical application.
The first product released was Dabigatran, which was proposed for many preventive and …
The first product released was Dabigatran, which was proposed for many preventive and …
An update on laboratory measurements of Dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma
J Amiral, C Dunois, C Amiral… - Transfusion and Apheresis …, 2016 - trasci.com
Abstract Use of Direct Oral Anticoagulants (DOACs) is continuously increasing for clinical
application. The first product released was Dabigatran, which was proposed for many …
application. The first product released was Dabigatran, which was proposed for many …
An update on laboratory measurements of Dabigatran: Smart specific and calibrated dedicated assays for measuring anti-IIa activity in plasma.
J Amiral, C Dunois, C Amiral… - … and Apheresis Science …, 2016 - europepmc.org
Use of Direct Oral Anticoagulants (DOACs) is continuously increasing for clinical application.
The first product released was Dabigatran, which was proposed for many preventive and …
The first product released was Dabigatran, which was proposed for many preventive and …